Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Laurus Labs is back in focus as the latest research update resets the stock's price ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Laurus Labs has been reset from ₹863.13 to ₹913.47, ...
SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...
Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...
Laurus Labs Ltd is quoting at Rs 1027.95, up 1.44% on the day as on 12:49 IST on the NSE. The stock is up 88.01% in last one year as compared to a 12.13% spurt in NIFTY and a 8.16% spurt in the Nifty ...
Hosted on MSN
Laurus Labs share price surges over 18% in June, outperforms Sensex. What's next for this pharma stock?
Laurus Labs share price rose over 2% during Monday's trading session to touch an 52-week high of ₹720.90 apiece on the BSE, marking the stock's third consecutive day of gains in a bullish trend. So ...
Laurus Labs reported a sharp rise in consolidated net profit for the December quarter, with earnings jumping to ₹252 crore from the ₹92 crore a year earlier, driven by a 26% year-on-year increase in ...
BENGALURU, Jan 30 (Reuters) - India's Laurus Labs Ltd LAUL.NS reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals and other ...
The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results